Abstract P ur p o s e : To compare the efficacy of computer-aided dosing using Coagclinic (a web-based software) with physician dosing in patients receiving warfarin for various cardiac indications. M e t h od s : In order to calculate the effectiveness of physician managed anticoagulation dosing, we calculated the "percentage of time international normalized ratio, INR, was in the therapeutic range" (TTR) for a random sample of 70 patients in the center. For each patient, 4 INR values were taken at 4 consecutive visits, before and after the installation of Coagclinic. Data on the doses given by physicians were collected at each visit and c o m p a r e d them with the pharmacy-based computer
INTRODUCTION
Patients whose compliance was > 80 % were informed about the study for possible recruitment. Upon understanding and accepting the policy and procedures to be used, they were asked to sign the informed consent form. Care was taken to ensure patient confidentiality. Comparison between the dosing of physician and doses given by computer software was made to evaluate the differences in TTR and dosing, if any. The computer software used was Coagclinic® a web based system in the United States, for management of anticoagulation dosing including warfarin, heparin, low molecular weight heparins (LMW Hs) and the new oral anticoagulants.
INCLUSION CRITERIA
For the purpose of completing this study, appopriate data extraction form was used to collect related data to be analyzed later. The prospective users' perceptions and attitudes toward the implementation of the new software were recorded and the notes taken will be useful in developing recommendations of the usage. The main source of data collected was the INR values recorded at various visits, patients' files in the clinic, and the interviews with patients' were considered as a source of some data related to patients' history. After obtaining their consent, 110 patients on warfarin were recruited. The INR was measured using point of care analyzer Coagucheck (Roche) and for any INR value > 4, additional testing was carried out using i-Stat analyzer (Abbott). This method was evaluated in our center to be sensitive, as Coagucheck was f ound not to be not very accurate for high INR readings in another study conducted in the same centre (unpublished data).
STATISTICAL ANALYSIS
The data were all saved in CoagClinic and then exported to Microsoft Excel®. Confounding variables such as sex, compliance, different indications for anticoagulation, were taken into account while carrying out the statistical analysis of the collected data. The data were then were exported to Minitab® to be used for statistical analysis and testing the research hypothesis. The power of the hypothesis was used to detect the expected sample size of the study, as the standardized difference was determined. By using the standardized difference, we would have a high chance of detecting a clinically important difference if it exists. The power and level of significance were assigned to be 0.8, and 0.05; respectively.
RESULTS
Of the 110 patients recruited for the study, 70 patients completed the study and for each patient, four INR values were recorded from 4 consecutive visits before and after implementation of the software. Since our unit of analysis was the INR, we had about 280 samples in each arm. Of these 70 patients completing the study, 42.8 % was male and 56.3 % female.
Descriptive data of sex, indications and TTR
Looking at the different indications for anticoagulation, there were 57.2% subjects with atrial fibrillation (AF), 20% with mitral valve replacement (MVR), 18.5%, with aortic valve replacement (AVR), and 4.3% with dual valve replacement (DVR) ( Table  1 ).
As shown in Table 2 , there is a significant difference between the dosing of the physicians at the clinic and the doses generated by the computer software since the calculated t-value is higher than the indexed one (p 0.05).
Impact of CoagClinic, gender and indications on TTR and dosing
After controlling all the confounders, including demographics and prescribers, we found that the percentage of patients kept at the TTR by physicians was 26 %, as 71 % f or the software within six month of the commencement of its application A significant difference (p = 0.015) was found between physicians' dosing and the dosing generated by the computer software (table  3) . Furthermore, there was no significant association between different indications for anticoagulation therapy and the calculated TTR (p = 0.61). Likewise, there was no significant association between gender and the calculated TTR (p=0.59). According to Van Leeuwen, the improved control of anticoagulant dosage (ICAD) algorithm is based on a model that comprises the pharmacokinetics and pharmacodynamics of the oral anticoagulant drug, the pharmacokinetics of the prothrombin complex, and the relationship between the activity of the prothrombin complex and the measured INR [11] . Ageno, et al, 1998 shows that the use of computer algorithms to assist phy sicians with their dosing decisions has been shown to lead to equal or improved quality of control of oral anticoagulant treatment as compared to unassisted dosing [12] .
The DAW N AC (anticoagulation) is one of the most widely used computer -dosage programs. Evidence of its value and that of other computer programs has been based previously only on laboratory evidence of "time in target INR range" (TTR).The DAW N AC computer dosage program proved as safe clinically as manual dosage by experienced medical staff [13] . SintromacW eb telecontrol is a new model for management of anticoagulated patients. It is an internet based tool. It was highly accepted and can be used by all patients regardless of their socio demographic characteristics [ Similar to other studies, the statistical analysis didn't show any significant differences in the groups that could be referred to demographic variables, prescribers, or indications. Accordingly, we can generalize the usage of this software for the purpose of the dosing of anticoagulation to improve the effectiveness of the clinic regardless of such confounders.
On the top of this, the optimization process has been conducted fairly in the presence of such high level of noncompliance of 20 %. Thus, the software might be also effective to help this cohort of patients to optimize their INR. However, the study was not designed to investigate the effect of sotware on compliance of patients, and an affirmative conclusion is required with another study.
The results obtained by the statistical analysis and the observation of the behavior of prospective users in our study show that the use of computer system in the dosing of anticoagulation therapy has many implications. The use of computer software in the dosing of anticoagulation therapy is to improve the process of calculating the doses and monitoring the therapeutic regimen as well. The results showed that there is significant difference between the doses given by physicians and the doses given by the computer software according to the latest guideline of dosing released by medical institutions that are updated almost every day. Seemingly, differences in dosing have resulted in a better response and longer time within the designated INR range In comparison to DAW N AC, and other software, CoagClinic has the ACCP (American college of chest physicians) guidelines implemented in it, provides the users with many alerts according to the best published and mostly updated guidelines. In addition to dosing, the user will be alerted on any potential drug-drug interactions and the expected INR changes, allowing the user to work proactively and keep the patient in the TTR as long as possible. Further, it is supplemented with a flow chart on what to do in case of prolonged INRs, and the best clinical recommendations in such scenarios. Several other features have not been utilized by us including, SMS services, heparin dosing, LMW H dosing, and dealing with the new oral anticoagulants. One of the main factors to consider, also, is the price. It is annually-renewed and dependant on number of patients. In our situation, the cost is $ 10,000 with a limit of 3000 patients. Several studies have shown that the CDSSs are cost-effective and the cost is justified. Our case has shown a clear clinical significance, and optimal outcomes.
The application process of computerized dosing system of anticoagulation therapy was passed through difficulties while implementing the process in many aspects. The computer software needs onthe-job (OJT) training programs for the benefit of users. The users of software faced problems such as logging in the software interface and many other problems related to the internet connection since the software is only accessible online. In our sit uation, the internet speed is acceptable and we had no disconnections during the whole period of the study. However, the most problematic issue that we had is the newly implemented e-prescription model in the hospital, leading to duplication, as we have to deal with two programs at the same time. This has restricted the optimal utilization of the software.
CONCLUSION
The use of CoagClinic improves the effectiveness of the anticoagulation dosing process and results in better TTR.
